Hvem vi hjælperVores videnskabProdukterResultater
Log indSpørgKom i gangfra 449 $
Træk
Blood in urine
Klinisk navn: Hematuria
The presence of blood in the urine. Hematuria may be gross hematuria (visible to the naked eye) or microscopic hematuria (detected by dipstick or microscopic examination of the urine).
Resumé
- Også kaldet
- High urine occult blood
Blood in urineHP:0000790
Hvem vi hjælperVores videnskabProdukterResultater
Log indSpørgKom i gangfra 449 $
Read the genes linked to Blood in urine, and the rest of your genome, with one test.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger
Bestil min Genome Test163 gener knyttet til Blood in urine
Ændringer i disse gener forårsager sjældne tilstande, hvor Blood in urine ses. De fleste med dette træk har ingen af disse tilstande, og et gen på denne liste siger intet om nogens eget genom.
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| APRTadenine phosphoribosyltransferase | Altid | I 1 tilstand |
| CTNScystinosin, lysosomal cystine transporter | Altid | I 1 tilstand |
| HMOX1heme oxygenase 1 | Altid | I 1 tilstand |
| IFT140intraflagellar transport 140 | Altid | I 2 tilstande |
| LAMB2laminin subunit beta 2 | Altid | I 1 tilstand |
| LARS2leucyl-tRNA synthetase 2, mitochondrial | Altid | I 1 tilstand |
| MCCC1methylcrotonyl-CoA carboxylase subunit 1 | Altid | I 1 tilstand |
| MYO1Emyosin IE | Altid | I 1 tilstand |
| PLD4phospholipase D family member 4 | Altid | I 1 tilstand |
| COL4A3collagen type IV alpha 3 chain | Meget ofte (80–99 %) | I 3 tilstande |
| COL4A4collagen type IV alpha 4 chain | Meget ofte (80–99 %) | I 4 tilstande |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Meget ofte (80–99 %) | I 2 tilstande |
| GLAgalactosidase alpha | Meget ofte (80–99 %) | I 1 tilstand |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Meget ofte (80–99 %) | I 1 tilstand |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Meget ofte (80–99 %) | I 1 tilstand |
| HOGA14-hydroxy-2-oxoglutarate aldolase 1 | Meget ofte (80–99 %) | I 1 tilstand |
| PRTN3proteinase 3 | Meget ofte (80–99 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Meget ofte (80–99 %) | I 3 tilstande |
| AGXTalanine--glyoxylate aminotransferase | Ofte (30–79 %) | I 2 tilstande |
| ALG5ALG5 dolichyl-phosphate beta-glucosyltransferase | Ofte (30–79 %) | I 1 tilstand |
| ALG9ALG9 alpha-1,2-mannosyltransferase | Ofte (30–79 %) | I 1 tilstand |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Ofte (30–79 %) | I 1 tilstand |
| BICC1BicC family RNA binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| C4Acomplement C4A (Chido/Rodgers blood group) | Ofte (30–79 %) | I 1 tilstand |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Ofte (30–79 %) | I 1 tilstand |
| CLDN19claudin 19 | Ofte (30–79 %) | I 1 tilstand |
| COL4A1collagen type IV alpha 1 chain | Ofte (30–79 %) | I 2 tilstande |
| COL4A5collagen type IV alpha 5 chain | Ofte (30–79 %) | I 1 tilstand |
| COL4A6collagen type IV alpha 6 chain | Ofte (30–79 %) | I 1 tilstand |
| CR2complement C3d receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| DGKEdiacylglycerol kinase epsilon | Ofte (30–79 %) | I 1 tilstand |
| DNAJB11DnaJ heat shock protein family (Hsp40) member B11 | Ofte (30–79 %) | I 1 tilstand |
| DNASE1deoxyribonuclease 1 | Ofte (30–79 %) | I 1 tilstand |
| DNASE1L3deoxyribonuclease 1L3 | Ofte (30–79 %) | I 1 tilstand |
| ETS1ETS proto-oncogene 1, transcription factor | Ofte (30–79 %) | I 1 tilstand |
| FCGR2BFc gamma receptor IIb | Ofte (30–79 %) | I 1 tilstand |
| FCGR3BFc gamma receptor IIIb | Ofte (30–79 %) | I 1 tilstand |
| GANABglucosidase II alpha subunit | Ofte (30–79 %) | I 1 tilstand |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Ofte (30–79 %) | I 2 tilstande |
Vis 123 gener mere
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| HNF1BHNF1 homeobox B | Ofte (30–79 %) | I 1 tilstand |
| HPRT1hypoxanthine phosphoribosyltransferase 1 | Ofte (30–79 %) | I 1 tilstand |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Ofte (30–79 %) | I 1 tilstand |
| IL10interleukin 10 | Ofte (30–79 %) | I 1 tilstand |
| IRAK1interleukin 1 receptor associated kinase 1 | Ofte (30–79 %) | I 2 tilstande |
| IRF5interferon regulatory factor 5 | Ofte (30–79 %) | I 1 tilstand |
| ITGA6integrin subunit alpha 6 | Ofte (30–79 %) | I 1 tilstand |
| ITGAMintegrin subunit alpha M | Ofte (30–79 %) | I 1 tilstand |
| ITGB4integrin subunit beta 4 | Ofte (30–79 %) | I 1 tilstand |
| JAZF1JAZF zinc finger 1 | Ofte (30–79 %) | I 1 tilstand |
| KANK2KN motif and ankyrin repeat domains 2 | Ofte (30–79 %) | I 1 tilstand |
| KIAA0319LKIAA0319 like | Ofte (30–79 %) | I 1 tilstand |
| MECP2methyl-CpG binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| NEK8NIMA related kinase 8 | Ofte (30–79 %) | I 1 tilstand |
| PAX2paired box 2 | Ofte (30–79 %) | I 1 tilstand |
| PDCD1programmed cell death 1 | Ofte (30–79 %) | I 1 tilstand |
| PFKMphosphofructokinase, muscle | Ofte (30–79 %) | I 1 tilstand |
| PKD1polycystin 1, transient receptor potential channel interacting | Ofte (30–79 %) | I 1 tilstand |
| PKD2polycystin 2, transient receptor potential cation channel | Ofte (30–79 %) | I 1 tilstand |
| PXKPX domain containing serine/threonine kinase like | Ofte (30–79 %) | I 1 tilstand |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Ofte (30–79 %) | I 1 tilstand |
| SERPINF2serpin family F member 2 | Ofte (30–79 %) | I 1 tilstand |
| SLC7A7solute carrier family 7 member 7 | Ofte (30–79 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Ofte (30–79 %) | I 2 tilstande |
| SPRY2sprouty RTK signaling antagonist 2 | Ofte (30–79 %) | I 1 tilstand |
| STAT4signal transducer and activator of transcription 4 | Ofte (30–79 %) | I 2 tilstande |
| STIM1stromal interaction molecule 1 | Ofte (30–79 %) | I 1 tilstand |
| TLR7toll like receptor 7 | Ofte (30–79 %) | I 1 tilstand |
| TNFAIP3TNF alpha induced protein 3 | Ofte (30–79 %) | I 1 tilstand |
| TNFSF4TNF superfamily member 4 | Ofte (30–79 %) | I 1 tilstand |
| TNIP1TNFAIP3 interacting protein 1 | Ofte (30–79 %) | I 1 tilstand |
| TREX1three prime repair exonuclease 1 | Ofte (30–79 %) | I 2 tilstande |
| TSC1TSC complex subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| TSC2TSC complex subunit 2 | Ofte (30–79 %) | I 1 tilstand |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Ofte (30–79 %) | I 1 tilstand |
| YAP1Yes1 associated transcriptional regulator | Ofte (30–79 %) | I 2 tilstande |
| ACP5acid phosphatase 5, tartrate resistant | Nogle gange (5–29 %) | I 1 tilstand |
| AGGF1angiogenic factor with G-patch and FHA domains 1 | Nogle gange (5–29 %) | I 1 tilstand |
| BNC2basonuclin zinc finger protein 2 | Nogle gange (5–29 %) | I 1 tilstand |
| CD109CD109 molecule | Nogle gange (5–29 %) | I 1 tilstand |
| CLEC7AC-type lectin domain containing 7A | Nogle gange (5–29 %) | I 1 tilstand |
| DLSTdihydrolipoamide S-succinyltransferase | Nogle gange (5–29 %) | I 1 tilstand |
| DNMT3ADNA methyltransferase 3 alpha | Nogle gange (5–29 %) | I 1 tilstand |
| DPH1diphthamide biosynthesis 1 | Nogle gange (5–29 %) | I 1 tilstand |
| EPAS1endothelial PAS domain protein 1 | Nogle gange (5–29 %) | I 1 tilstand |
| F10coagulation factor X | Nogle gange (5–29 %) | I 1 tilstand |
| F5coagulation factor V | Nogle gange (5–29 %) | I 1 tilstand |
| F8coagulation factor VIII | Nogle gange (5–29 %) | I 1 tilstand |
| F9coagulation factor IX | Nogle gange (5–29 %) | I 1 tilstand |
| FAN1FANCD2 and FANCI associated nuclease 1 | Nogle gange (5–29 %) | I 1 tilstand |
| FCGR2CFc gamma receptor IIc (gene/pseudogene) | Nogle gange (5–29 %) | I 1 tilstand |
| FHfumarate hydratase | Nogle gange (5–29 %) | I 1 tilstand |
| GBA1glucosylceramidase beta 1 | Nogle gange (5–29 %) | I 2 tilstande |
| GP1BAglycoprotein Ib platelet subunit alpha | Nogle gange (5–29 %) | I 1 tilstand |
| GP1BBglycoprotein Ib platelet subunit beta | Nogle gange (5–29 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Nogle gange (5–29 %) | I 1 tilstand |
| IL17Finterleukin 17F | Nogle gange (5–29 %) | I 1 tilstand |
| IL17RAinterleukin 17 receptor A | Nogle gange (5–29 %) | I 1 tilstand |
| IL17RCinterleukin 17 receptor C | Nogle gange (5–29 %) | I 1 tilstand |
| ITGA2integrin subunit alpha 2 | Nogle gange (5–29 %) | I 1 tilstand |
| ITGA2Bintegrin subunit alpha 2b | Nogle gange (5–29 %) | I 1 tilstand |
| ITGB3integrin subunit beta 3 | Nogle gange (5–29 %) | I 1 tilstand |
| KIF1Bkinesin family member 1B | Nogle gange (5–29 %) | I 1 tilstand |
| LMAN1lectin, mannose binding 1 | Nogle gange (5–29 %) | I 1 tilstand |
| LMX1BLIM homeobox transcription factor 1 beta | Nogle gange (5–29 %) | I 2 tilstande |
| MAXMYC associated transcriptional regulator X | Nogle gange (5–29 %) | I 1 tilstand |
| MCFD2multiple coagulation factor deficiency 2, ER cargo receptor complex subunit | Nogle gange (5–29 %) | I 1 tilstand |
| MDH2malate dehydrogenase 2 | Nogle gange (5–29 %) | I 1 tilstand |
| NF1neurofibromin 1 | Nogle gange (5–29 %) | I 1 tilstand |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Nogle gange (5–29 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Nogle gange (5–29 %) | I 1 tilstand |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Nogle gange (5–29 %) | I 1 tilstand |
| RETret proto-oncogene | Nogle gange (5–29 %) | I 2 tilstande |
| SCARB2scavenger receptor class B member 2 | Nogle gange (5–29 %) | I 1 tilstand |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Nogle gange (5–29 %) | I 1 tilstand |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Nogle gange (5–29 %) | I 1 tilstand |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Nogle gange (5–29 %) | I 2 tilstande |
| SDHCsuccinate dehydrogenase complex subunit C | Nogle gange (5–29 %) | I 1 tilstand |
| SDHDsuccinate dehydrogenase complex subunit D | Nogle gange (5–29 %) | I 2 tilstande |
| SLC22A12solute carrier family 22 member 12 | Nogle gange (5–29 %) | I 1 tilstand |
| SLC25A11solute carrier family 25 member 11 | Nogle gange (5–29 %) | I 1 tilstand |
| SLC2A9solute carrier family 2 member 9 | Nogle gange (5–29 %) | I 1 tilstand |
| SREBF1sterol regulatory element binding transcription factor 1 | Nogle gange (5–29 %) | I 1 tilstand |
| TMEM127transmembrane protein 127 | Nogle gange (5–29 %) | I 1 tilstand |
| TRAF3IP2TRAF3 interacting protein 2 | Nogle gange (5–29 %) | I 1 tilstand |
| UMODuromodulin | Nogle gange (5–29 %) | I 1 tilstand |
| VHLvon Hippel-Lindau tumor suppressor | Nogle gange (5–29 %) | I 2 tilstande |
| BCORBCL6 corepressor | Sjældent (1–4%) | I 1 tilstand |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Sjældent (1–4%) | I 1 tilstand |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Sjældent (1–4%) | I 1 tilstand |
| NABP1nucleic acid binding protein 1 | Sjældent (1–4%) | I 1 tilstand |
| NPM1nucleophosmin 1 | Sjældent (1–4%) | I 1 tilstand |
| NUMA1nuclear mitotic apparatus protein 1 | Sjældent (1–4%) | I 1 tilstand |
| PMLPML nuclear body scaffold | Sjældent (1–4%) | I 1 tilstand |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Sjældent (1–4%) | I 1 tilstand |
| RARAretinoic acid receptor alpha | Sjældent (1–4%) | I 1 tilstand |
| SLC34A2solute carrier family 34 member 2 | Sjældent (1–4%) | I 1 tilstand |
| SLC5A1solute carrier family 5 member 1 | Sjældent (1–4%) | I 1 tilstand |
| SPTBN1spectrin beta, non-erythrocytic 1 | Sjældent (1–4%) | I 1 tilstand |
| STAT3signal transducer and activator of transcription 3 | Sjældent (1–4%) | I 1 tilstand |
| STAT5Bsignal transducer and activator of transcription 5B | Sjældent (1–4%) | I 1 tilstand |
| TBL1XR1TBL1X/Y related 1 | Sjældent (1–4%) | I 1 tilstand |
| ZBTB16zinc finger and BTB domain containing 16 | Sjældent (1–4%) | I 1 tilstand |
| C3complement C3 | Ikke registreret | I 1 tilstand |
| CD2APCD2 associated protein | Ikke registreret | I 1 tilstand |
| CD46CD46 molecule | Ikke registreret | I 1 tilstand |
| CFBcomplement factor B | Ikke registreret | I 1 tilstand |
| CFHcomplement factor H | Ikke registreret | I 1 tilstand |
| CFIcomplement factor I | Ikke registreret | I 1 tilstand |
| CLDN16claudin 16 | Ikke registreret | I 1 tilstand |
| FGAfibrinogen alpha chain | Ikke registreret | I 1 tilstand |
| GATA3GATA binding protein 3 | Ikke registreret | I 1 tilstand |
| GRHPRglyoxylate and hydroxypyruvate reductase | Ikke registreret | I 1 tilstand |
| HBBhemoglobin subunit beta | Ikke registreret | I 1 tilstand |
| LMNB2lamin B2 | Ikke registreret | I 1 tilstand |
| MMACHCmetabolism of cobalamin associated C | Ikke registreret | I 1 tilstand |
| NOTCH2notch receptor 2 | Ikke registreret | I 1 tilstand |
| NUP133nucleoporin 133 | Ikke registreret | I 1 tilstand |
| NUP93nucleoporin 93 | Ikke registreret | I 1 tilstand |
| PRDX1peroxiredoxin 1 | Ikke registreret | I 1 tilstand |
| SLC37A4solute carrier family 37 member 4 | Ikke registreret | I 1 tilstand |
| THBDthrombomodulin | Ikke registreret | I 1 tilstand |
| UMPSuridine monophosphate synthetase | Ikke registreret | I 1 tilstand |
Hvor hyppigt det ses hos personer med en af genets tilstande, den hyppigste værdi på tværs af dem, sådan som Human Phenotype Ontology registrerer det. Disse sider beskriver egenskaber og den forskning, der ligger bag dem. De er ikke en diagnose, og hvis du har spørgsmål om symptomer, bør du spørge en læge eller genetisk rådgiver.
Snævrere træk
Bredere træk
Hvor oplysningerne kommer fra
- Human Phenotype Ontology, udgivelse 2026-09-01: egenskaben, dens navne, definition og de gener, der er knyttet til den. Læs mere på hpo.jax.org.
- Dataudgivelse 2026.10.16-c6eea6bf.
Hvem vi hjælperVores videnskabProdukterResultater
Log indSpørgKom i gangfra 449 $
Én test. Svar for hele livet.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger